Inhibition of the epidermal growth factor receptor (EGFR) is an established treatment that
extends patient survival across a variety of tumor types. EGFR inhibitors fall into two main …

In recent years, research on tetracycline antibiotics has gradually shifted from their
antibacterial effects to anticancer effects. Doxycycline, minocycline, and tigecycline as the …

Biomarker detection is one of the most important and challenging problems in cancer
studies. Recently, non-coding RNA based biomarkers such as miRNA expression levels …

Colorectal cancer (CRC) is an important public health issue, in terms of incidence and
mortality, with approximately 1.8 million new cases reported worldwide in 2018 …

Topical and systemic prophylactic measures, which are administered before the
development of epidermal growth factor receptor (EGFR)‐related acneiform rash, are …

Epidermal growth factor receptor inhibitors (EGFRIs) are increasingly being used for
malignancies of epithelial origin. Though these therapies are better tolerated than …

Purpose Anti-epidermal growth factor receptor (anti-EGFR) monoclonal antibodies are
effective in treating RAS wild-type metastatic colorectal cancer (mCRC). However, their …

The past decades have witnessed a rapid increase in the use of molecularly targeted
therapies. One class of agents includes the epidermal growth factor receptor inhibitors …

Background: Management of cancer treatment–related skin toxicities can minimize treatment
disruptions and improve patient well-being. Objectives: This guideline aims to support …

The use of targeted therapies, when added to conventional chemotherapy, has significantly
improved clinical outcomes and survival of cancer patients. While targeted therapies do not …